Gener8  

2560 Junction Ave.
San Jose,  CA  95134

United States
https://www.gener8.net/

• Booth: 811

Gener8 guides innovators along the uncertain and obstacle-strewn path to market. With over 20 years of experience, talented engineers across multiple disciplines, and an integrated end-to-end process, we offer innovators a one-stop solution to get their devices to market quickly. Our unique collaborative style and candid partnership position us as trusted advisors guiding moment to market. We offer engineering services in instrumentation, software, and microfluidic consumables, as well as manufacturing services.

 Press Releases

• Gener8 Celebrates 20 Years of Business and Continued Growth (Jun 08, 2023)

  Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), celebrates the company’s 20th anniversary this month. Since its founding in September 2002, Gener8 has developed into a full product lifecycle engineering and manufacturing partner, successfully serving the biotech, life sciences, and medical device industries.

  “I feel lucky and honored by the team of amazing employees and customers that have assembled to make Gener8 what it is today. I had no idea when Gener8 started in my garage that it would grow to become the leading global life sciences company that it is now”, said David Klein, founder of Gener8. “None of this would have been possible without the dedicated team who shared a vision and worked tirelessly to achieve it”.

  In recent years, Gener8 has expanded its core instrument engineering capabilities through strategic acquisitions in 2019, adding microfluidics cartridge design, development, and manufacturing, and in 2021, adding full lifecycle software development capabilities. Gener8 now offers comprehensive turnkey solutions for instrument, consumable, and software design, development, and manufacturing, under one roof.

  “These synergistic capabilities provide significant value to our clients by coordinating all aspects of a project, under one roof”, said Jerry Jurkiewicz, Gener8 CEO. “As an evolving company, the new Gener8 logo reflects the seamless connection we provide through each stage of the product lifecycle – from product development and launch through to manufacturing. Gener8 now offers a true end-to-end solution.”

  Gener8 is continuing to expand its services by introducing a cost-competitive manufacturing site in Costa Rica in Q4 of this year. In addition, Gener8 will relocate its current company headquarters to a larger facility in San Jose. Gener8’s leadership anticipates continued growth and expansion thanks to the dedication of the entire staff to emerging technology and the trusted confidence of their clientele.

• Gener8 Announces Launch of New ISO-Certified Manufacturing Facility in Costa Rica, Bolstering Global Production and Assembly Capabilities (Jun 08, 2023)

  "Gener8 LLC (“Gener8”), a portfolio firm of Sverica Capital Management LP (“Sverica”), is thrilled to announce today its expansion into Costa Rica with the inauguration of a brand new 30,000 sqft manufacturing facility situated in the La Lima Free trade zone park, Cartago, Costa Rica.

  The sophisticated facility, designed for high-tech instrument manufacturing and cleanroom assembly, is equipped with an ESD-controlled environment and an ISO Class 8 cleanroom. This milestone achievement comes from Gener8 Costa Rica successfully obtaining ISO 9001 and ISO 13485 certificates.

  "Our strategic move to Costa Rica allows us to deliver a comprehensive product life cycle solution for our customers - encompassing not only hardware, software, and micro-fluidic cartridges design services, but now, efficient, high-volume manufacturing capabilities," said Jerry Jurkiewicz, Gener8 CEO.

  Jurkiewicz stated, "Costa Rica was chosen for its pool of skilled workforce, proximity to our US operations, and proactive business-friendly policies. I am grateful to the Costa Rican government and CINDE for fostering such a conducive business environment."

  The Minister of Foreign Trade, Manuel Tovar, responded, “Costa Rica is a recognized regional leader in advanced manufacturing processes. We're proud that Gener8 has chosen to establish its first manufacturing plant outside the United States here. This investment enables 60 Costa Ricans to secure quality employment in electromechanical instrument manufacturing. Our strategic positioning favors complex manufacturing industries and promotes product diversification, collectively energizing our economy."

  Managing director of CINDE, Jorge Sequeira, observed, "Gener8's entrance in our territory propels us forward, beyond merely designing and manufacturing complex instruments. It spurs the research and development of groundbreaking technologies for medical diagnostics and clinical laboratory equipment. This is a testament to our consistent efforts to be a leading global destination for medical device companies, currently holding fifth place globally."

  Commencing with a strong team of 60 employees, Gener8 aims to expand its headcount over the next few years significantly. With an initial staff of 27, the company anticipates dynamic growth.

  "Our high-tech design and manufacturing processes will create stimulating job opportunities for engineers and technicians specializing in mechatronics, systems integration, and software testing," said Alfred Macha, Vice-president of Costa Rica Operations, Gener8."

• Gener8 Announces Relocation and Expansion of Boston Operations (Jun 26, 2023)

  Boston, MA – [June 26, 2023] – Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), is pleased to announce its relocation and expansion of its Boston operations to a more substantial facility. This strategic move is designed to accommodate the company’s rapid expansion, with a growing headcount of dedicated technical professionals, and to facilitate future growth projections.

  The new facility, located at 181 Ballardvale Street, Suite 102B, Wilmington, MA 01887, will offer customers easier and open access to their projects. It will feature several state-of-the-art labs, including a spacious engineering lab for enhanced research and development (R&D) capabilities, an electronics lab, an expanded chemistry lab capable of handling biologic materials, and an optics lab for advanced optical system design and testing. Furthermore, Gener8 will augment its in-house prototyping capabilities by expanding the machine shop and the additive manufacturing lab.

  According to Vladimir Fuflyigin, Gener8’s Managing Director in Boston, “The new site will not only provide our customers with improved access to their projects but will also house cutting-edge labs to enhance our R&D capabilities. We are excited to expand our engineering, electronics, chemistry, and optics labs and prototyping facilities, enabling us to deliver even higher quality and innovative solutions.”

  Gener8’s CEO, Jerry Jurkiewicz, emphasizes the significance of this relocation. “Our continuous growth has necessitated a new home. Moving to a state-of-the-art facility represents a significant step forward for our Boston operations. It supports our expanding team, boosts operational efficiency, and enhances our capacity to deliver high-quality products and services. This move allows us to innovate and push the boundaries of what we can achieve.”

  The decision to relocate underscores Gener8’s commitment to investing in infrastructure and resources to foster innovation, enhance capabilities, and maintain a leadership position in the industry.

  Jerry Jurkiewicz concludes, “This move marks a significant milestone in our growth journey. With this new setup, we are better positioned to deliver advanced, tailored solutions to our clients while providing our employees with an enriching and progressive work environment. We are thrilled about this new chapter in Gener8’s story.”

  The new Gener8 Boston facility, currently in full operation, is staffed with engineers, scientists, and support personnel dedicated to driving innovation and success.

  For media inquiries, please contact:

  Anna Clark, Marketing Communications Manager, Gener8
  aclark@gener8.net

  
  About Gener8
  Gener8, founded in 2002, offers complete product lifecycle engineering and manufacturing for highly complex instruments and products within the highly regulated Biotechnology, Life Sciences, and Medical Device markets. The services that Gener8 provides allow for an agile and fast time-to-market solution that results in high-reliability solutions for customers. With locations in San Jose, CA; Boston, MA; Carlsbad, CA; Indianapolis, IN; and La Lima, Costa Rica, Gener8 operates in the corridors of innovation and maintains all industry-specific certifications. For more information, please visit www.gener8.net.

  https://www.gener8.net/gener8-announces-relocation-and-expansion-of-boston-operations/

 Additional Info